Sara Bonstein
2020 - INSMED
In 2020, Sara Bonstein earned a total compensation of $2.7M as Chief Financial Officer at INSMED.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $224,700 |
| Option Awards | $2,024,075 |
| Salary | $386,615 |
| Other | $11,400 |
| Total | $2,721,790 |
Bonstein received $2M in option awards, accounting for 74% of the total pay in 2020.
Bonstein also received $75K in bonus, $224.7K in non-equity incentive plan, $386.6K in salary and $11.4K in other compensation.
Rankings
In 2020, Sara Bonstein's compensation ranked 4,228th out of 13,090 executives tracked by ExecPay. In other words, Bonstein earned more than 67.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,228 out of 13,090 | 68th |
Division Manufacturing | 1,709 out of 5,617 | 70th |
Major group Chemicals And Allied Products | 664 out of 2,248 | 71st |
Industry group Drugs | 567 out of 1,948 | 71st |
Industry Pharmaceutical Preparations | 433 out of 1,453 | 70th |
Source: SEC filing on April 1, 2021.
Bonstein's colleagues
We found five more compensation records of executives who worked with Sara Bonstein at INSMED in 2020.